US Stocks
/
Decoy Therapeutics Inc. Share Price
Decoy Therapeutics Inc. Share Price

Decoy Therapeutics Inc. Share Price

NASDAQ: DCOY | Micro Cap
$1.47
-$0.05 (-3.29%) Last updated on 09 Oct, 2026 | 22:43 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Decoy Therapeutics Inc. Stock Performance

Open
$1.47
Prev. Close
$1.52
Circuit Range
N/A
Day Range
$1.47 - $1.47
Year Range
$0.57 - $13.51
Volume
300
Average Traded
$1.47

Decoy Therapeutics Inc. Share Price Today

As of 11 October 2026, Decoy Therapeutics Inc.'s share price is $1.47. The stock opened at $1.47, compared to its previous close of $1.52. During today's trading session, Decoy Therapeutics Inc.'s share price traded between $1.47 and $1.47, with an average price of $1.47. Over the past 52 weeks, the stock has recorded a high of $13.51 and a low of $0.57. In terms of performance, Decoy Therapeutics Inc.'s share price has declined by 73.47% over the last six months and is up 90.41% on a year-on-year basis.

Decoy Therapeutics Inc. Share Price Chart

$1.47$1.47
L
Show Current Price
H

Decoy Therapeutics Inc. Stock Fundamentals & Key Indicators

Market Cap
$142541.49
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-22.05
Revenue (TTM)
N/A
Return On Equity (TTM)
-334.41%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
N/A

Decoy Therapeutics Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2026Jun 2026
Revenue$0.00$0.23
Net Profit-$2.22-$2.37
Net Profit MarginN/A-1030.43%
Income ChangeN/A-6.76%

About Decoy Therapeutics Inc.

Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.

Decoy Therapeutics Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.92
$1.47
-25.19%
Sep 2026
$2.89
$1.97
-35.36%
Aug 2026
$4.20
$3.04
-25.31%
Jul 2026
$6.29
$4.07
-44.78%
Jun 2026
$9.09
$7.37
-6.23%
May 2026
$5.49
$7.86
+41.88%
Apr 2026
$6.27
$5.54
-17.44%
Mar 2026
$0.68
$6.71
+879.56%
Feb 2026
$0.69
$0.69
-11.27%
Jan 2026
$0.80
$0.77
N/A

DCOY Share Price FAQs

What is Decoy Therapeutics Inc. share price today?

chevron-up
Decoy Therapeutics Inc. share price today is $1.47 as on October 9, 2026 at 10:43 pm IST.

What is the 52 week high and 52 week low of Decoy Therapeutics Inc. stock?

chevron-up
The 52 week high of Decoy Therapeutics Inc. stock is $13.51, while the 52 week low is $0.57 as of 9 Oct '26.

What is DCOY's market capitalisation today?

chevron-up
DCOY market capitalisation is $142541.49 as of October 11, 2026, at 5:12 am IST.

What is DCOY's net income for the last quarter?

chevron-up
DCOY's net income for the last quarter is -2.37B USD.

What is the 5 year returns of DCOY?

chevron-up
The 5 year returns of DCOY is 90.41% as on 9 Oct '26.

What is the high & low stock price of DCOY today?

chevron-up
DCOY stock price hit a high of $1.47 and low of $1.47 as of 9 Oct '26.

Can I buy DCOY shares in India?

chevron-up
Yes. You can buy DCOY in India by opening an international trading account.